HomeKAPA • NYSEAMERICAN
add
Kairos Pharma Ltd
Previous close
$0.86
Day range
$0.81 - $0.85
Year range
$0.40 - $3.25
Market cap
16.94M USD
Avg Volume
229.03K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.44M | 274.67% |
Net income | -1.40M | -33.52% |
Net profit margin | — | — |
Earnings per share | -0.07 | 30.00% |
EBITDA | -1.40M | -306.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.58M | 73.30% |
Total assets | 8.07M | 61.19% |
Total liabilities | 402.00K | -75.96% |
Total equity | 7.66M | — |
Shares outstanding | 20.82M | — |
Price to book | 2.32 | — |
Return on assets | -48.68% | — |
Return on capital | -52.52% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.40M | -33.52% |
Cash from operations | -838.00K | 58.51% |
Cash from investing | — | — |
Cash from financing | 3.38M | -35.22% |
Net change in cash | 2.54M | -20.49% |
Free cash flow | -345.88K | 88.50% |
About
Founded
2013
Headquarters
Website
Employees
3
